drugset / Trial / NCT00606099
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to evaluate the efficacy and safety of telbivudine 600mg versus adefovir dipivoxil 10mg in patients with compensated chronic hepatitis B.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-11
- Completion
- —
Outcome
Outcome not reported
Stopped: “study was cancelled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adefovir dipivoxil | Small molecule | 10 mg | — |
| Subject | Telbivudine | Small molecule | 600 mg | — |